Calling action. In a letter dated July 9, 2025, the US Food and Drug Administration (FDA) issued a clear call to action for manufacturers, distributors and retailers of infant formula, baby food and children's food. The agency highlighted the urgent need for transparency and faster communication regarding food recalls, taking into account recent incidents involving chemical contaminants in products aimed at children, particularly the most vulnerable consumers.
FDA infant prescription regulations. Infant prescriptions are defined under the Federal Food, Drug and Cosmetics Act (FD&C Act) as foods that are “defined as foods that represent special diets only as special foods for babies due to the simulation of breast milk or their compatibility” (FD&CAct §201).
Supply chain disruption. The disruption in infant formula supply in 2022, caused in part by the temporary closure of major infant formula manufacturing facilities, has shown that it will help create a more resilient US supply of infant formulas and avoid future shortages. The FDA says it is committed to supporting the availability of a proper supply of safe and nutritionally appropriate infant formulas to avoid future risks of lack of access to only nutritional sources for vulnerable populations.
Partnership with the FDA industry. The FDA is seeking stronger partnerships with industry leaders to overhaul their recall communications systems. It will notify agencies as soon as they launch a recall in line with existing regulations and encourage businesses to expand their public notification efforts when it affects infants and children. The FDA says it acknowledges that the public is increasingly expecting timely and detailed information about food recalls, particularly for vulnerable populations.
To support this transformation, the FDA has outlined both short-term and long-term initiatives.
Short-term goals include launching consumer-friendly recall web pages, improving access to recall data, and strengthening risk communication strategies. The long-term goals focus on digital modernization, including AI-assisted data analytics and new digital platforms for industry recall submissions.
The FDA emphasizes that these efforts will require ongoing collaboration and investment from both the public and private sectors. Ultimately, the initiative aims to empower parents, protect children's health, and create a stronger, more transparent food safety system.
Conclusion. The FDA is responsible for ensuring the safety and nutritional content of infant prescriptions, baby foods and children's foods. If problems arise with the manufacture or labeling of these products, the FDA must work closely with the industry to ensure that you are informed in a timely manner of circumstances that will guarantee product recalls. Improved communication and transparency can help protect the health and well-being of infants, babies and older children. The industry should continue to monitor regulatory changes in food chemical requirements targeting these vulnerable populations and work with the FDA to respond promptly to emerging concerns.
Want to know more?
The content of this article is intended to provide a general guide to the subject matter. You should seek expert advice on your particular situation.
